Treatment Outcomes and Clinical Relevance in Patients with Double Expressor DLBCL

BACKGROUND: Double-expressor lymphoma (DEL) was found to account for 20–30% of DLBCL. We conducted this study to analyze the survival, the clinical presentation, and the factors associated with treatment outcomes in DEL-DLBCL. METHODS: A retrospective study of 291 patients diagnosed with DLBCL durin...

Descripción completa

Detalles Bibliográficos
Autores principales: Rungwittayatiwat, Sirapat, Boonsakan, Paisarn, Chantrathammachart, Pichika, Puavilai, Teeraya, Pukiat, Sulada, Phusanti, Sithakom, Boonyawat, Kochawan, Wacharapornin, Pathawut, Angchaisuksiri, Pantep, Ungkanont, Artit, Chuncharunee, Suporn, Niparuck, Pimjai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577552/
https://www.ncbi.nlm.nih.gov/pubmed/34804437
http://dx.doi.org/10.4084/MJHID.2021.063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577552/
https://www.ncbi.nlm.nih.gov/pubmed/34804437
http://dx.doi.org/10.4084/MJHID.2021.063

Ejemplares similares